Atlas Trials

Managed Access Programs for BYL719, Alpelisib

Clinical trial NCT04085653 · AVAILABLE

Trial details

NCT number
NCT04085653
Sponsor
Novartis Pharmaceuticals
Status
AVAILABLE
Study type
EXPANDED_ACCESS
PIK3CA-Related Overgrowth Spectrum (PROS)Breast Cancer

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.